SEC EDGAR Filing Information

Form 4 -- Statement of changes in beneficial ownership of securities

Period of Report: 2007-08-29
Filing Date Changed: 2007-08-29
Documents: 1

SEC Accession No.
0001140361-07-017427
Filing date: 2007-08-29
Accepted: 2007-08-29 12:52:59

Table of submitted documents:

Seq	Type	Document	Size	Description
1	4	doc1.html		FORM 4
1	4	doc1.xml	3245	FORM 4

		0001140361-07-017427.txt	5363	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Issuer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131
305-534-3383

Mailing Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131

MYRIANTHOPOULOS EVAN (Reporting) (0001050955)
Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 071086565

Business Address
DISCOVERY LABORATORIES INC
509 MADISON AVE 14TH FLOOR
NEW YORK NY 10022
2122234504

Mailing Address
509 MADISON AVE 14TH FL
NEW YORK NY 10022